- Home
- KNSA vs SIGI Comparison
KNSA vs SIGI Comparison
Compare KNSA & SIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KNSA | SIGI |
|---|---|---|
| Founded | 2015 | 1926 |
| Country | United Kingdom | United States |
| Employees | N/A | 2800 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.8B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | KNSA | SIGI |
|---|---|---|
| Price | $63.61 | $98.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | $60.86 | ★ $85.80 |
| AVG Volume (30 Days) | ★ 996.3K | 480.8K |
| Earning Date | 04-28-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.03% |
| EPS Growth | ★ 225.00 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $677,564,000.00 | N/A |
| Revenue This Year | $37.48 | $0.41 |
| Revenue Next Year | $17.87 | $4.81 |
| P/E Ratio | $232.74 | ★ $11.38 |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $26.27 | $71.75 |
| 52 Week High | $67.53 | $100.40 |
Technical Indicators
Market Signals| Indicator | KNSA | SIGI |
|---|---|---|
| Relative Strength Index (RSI) | 58.22 | 61.63 |
| Support Level | $37.62 | $76.54 |
| Resistance Level | $67.53 | $100.40 |
| Average True Range (ATR) | 2.72 | 2.25 |
| MACD | -0.39 | -0.29 |
| Stochastic Oscillator | 46.82 | 76.16 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About SIGI Selective Insurance Group Inc.
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. Majority of revenue is gained from Standard Commercial Lines segment, which comprises of property and casualty insurance products and services provided in the standard marketplace to commercial enterprises, which are typically businesses, non-profit organizations, and local government agencies.